MB, Levis & Associates’s Aptiv APTV Stock Holding History

MB, Levis & Associates’s Portfolio APTV Stock Details APTV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-125	Closed	-$14K	–	285
2023 Q1	$14K	Hold	125	–	–	0.01%	173
2022 Q4	$11.6K	Buy	+125	New	+$11.9K	0.01%	174

Other funds holding APTV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

MB, Levis & Associates's APTV Position: Q2 2023 in Review

MB, Levis & Associates sold out of Aptiv (APTV) in Q2 2023, closing a stake of 125 shares — an estimated $14K sold.

MB, Levis & Associates first reported a position in APTV in Q4 2022 and held it in 2 quarters. The position peaked at $14K in Q1 2023. 734 funds tracked by Wall St. Rank hold APTV as of Q2 2023.

MB, Levis & Associates reported no remaining Aptiv position as of Q2 2023 after selling out during the quarter.
MB, Levis & Associates sold 125 Aptiv shares in Q2 2023, an estimated $14K.
MB, Levis & Associates first reported a position in Aptiv in Q4 2022 and held it in 2 quarters.
MB, Levis & Associates's Aptiv position peaked at $14K in Q1 2023.
734 funds tracked by Wall St. Rank held Aptiv as of Q2 2023.

Based on MB, Levis & Associates's 13F filing for Q2 2023, filed 7 May 2025.